Enhance exam efficiency with improved ergonomics and high-speed processing
FibroScan® Expert 630 is a point-of-care solution designed for high-volume hospital settings.
Complete Solution
Spleen Stiffness Measurement
All Patient Morphologies
Renowned & Endorsed
Unique capabilities of SSM by VCTE®
Assess and Monitor Portal Hypertension*
SSM by VCTE® helps to assess and monitor portal hypertension, the main driver of cirrhosis, in a quick and non-invasive manner.
Helps to Assess the Presence of Oesophageal Varices*
SSM by VCTE® can provide added value to help identify high-risk varices and prioritise endoscopies.
Determine Surgery*
SSM by VCTE® has the potential to triage patients in the general surgical population by assessing portal hypertension, a known risk factor, prior to surgery.
Operator perspectives
What our users say about Spleen Stiffness Measurement
Extend FibroScan® use
Beyond FibroScan®, Echosens develops solutions to optimise the management of liver diseases and assist in guiding treatment decisions.
-
Guided VCTE®
Seamless liver health assessment for all
-
VCTE® probe
Optimize measurement accuracy on all patient morphologies
-
Liver Health Management
Cloud-based solution to assist clinicians in providing comprehensive liver care.
-
FibroScan® Gateway
Optimize clinical workflows with real-time secure data transmission
User testimonial
Read all testimonials
*SSM is a marker for non-invasive evaluation of spleen stiffness which has been used in a clinical setting to assess portal hypertension and for variceal surveillance.
1.Stefanescu H, et al. A novel spleen-dedicated stiffness measurement by FibroScan improves the screening of high-risk oesophageal varices. Liver Int. 2020;40(1):175-185. doi:10.1111/liv.14228.
2.Dajti, Elton et al. “A Combined Baveno VII and Spleen Stiffness Algorithm to Improve the Noninvasive Diagnosis of Clinically Significant Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease.” The American journal of gastroenterology vol. 117,11 (2022): 1825-1833. doi:10.14309/ajg.0000000000001887.
3.Baveno VII – R. de Franchis et al. Renewing consensus in portal hypertension. Journal of hepatology vol. 76,4 (2022): 959-974. doi:10.1016/j.jhep.2021.12.022.
FibroScan® 630 Expert is a class IIa medical device according to Rule 10 of ANNEX VIII of Regulation EU 2017/745 (CE 0459) and and is manufactured by Echosens™. FibroScan® 630 Expert is intended to provide: Liver stiffness measurements at a shear wave frequency of 50 Hz, liver ultrasound attenuation measurements (CAP: Controlled Attenuation Parameter) at 3.5 MHz and spleen stiffness measurements at a shear wave frequency of 100 Hz. FibroScan® 630 Expert is a non-invasive device intended to aid clinical management, diagnosis, and monitoring of patients with confirmed or suspected chronic liver disease, as part of an overall assessment of the liver. FibroScan® device may aid the healthcare professionals in the assessment of liver fibrosis, steatosis, and in determining the likelihood of cirrhosis, and its complications. FibroScan® device is used, in conjunction with other clinical and laboratory data, during liver assessment in patients with confirmed or suspected chronic liver disease. Examinations with FibroScan® device shall be performed by an operator who has been certified by the manufacturer or its approved local representative. Operators are expressly recommended to carefully read the instructions given in the user manual and on the labelling of these products. Check cost defrayal conditions with paying bodies.